118 related articles for article (PubMed ID: 18780601)
1. Association of CT60 polymorphism of the CTLA4 gene with Graves' disease in Taiwanese children.
Tsai ST; Huang CY; Lo FS; Chang YT; Tanizawa T; Chen CK; Wang ZC; Liu HF; Chu CC; Lin M; Lin CH; Li HJ; Lee YJ
J Pediatr Endocrinol Metab; 2008 Jul; 21(7):665-72. PubMed ID: 18780601
[TBL] [Abstract][Full Text] [Related]
2. CT60 single nucleotide polymorphism of the CTLA-4 gene is associated with susceptibility to Graves' disease in the Taiwanese population.
Weng YC; Wu MJ; Lin WS
Ann Clin Lab Sci; 2005; 35(3):259-64. PubMed ID: 16081581
[TBL] [Abstract][Full Text] [Related]
3. Association of CTLA-4 +49 A/G and CT60 Gene Polymorphism with Graves' Disease.
Fouad NA; Saeed AM; Mahedy AW
Egypt J Immunol; 2017 Jun; 24(2):63-70. PubMed ID: 29528580
[TBL] [Abstract][Full Text] [Related]
4. Association of Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA4) Gene Polymorphisms with Autoimmune Thyroid Disease in Children and Adults: Case-Control Study.
Ting WH; Chien MN; Lo FS; Wang CH; Huang CY; Lin CL; Lin WS; Chang TY; Yang HW; Chen WF; Lien YP; Cheng BW; Lin CH; Chen CC; Wu YL; Hung CM; Li HJ; Chan CI; Lee YJ
PLoS One; 2016; 11(4):e0154394. PubMed ID: 27111218
[TBL] [Abstract][Full Text] [Related]
5. CTLA4 gene and Graves' disease: association of Graves' disease with the CTLA4 exon 1 and intron 1 polymorphisms, but not with the promoter polymorphism.
Vaidya B; Oakes EJ; Imrie H; Dickinson AJ; Perros P; Kendall-Taylor P; Pearce SH
Clin Endocrinol (Oxf); 2003 Jun; 58(6):732-5. PubMed ID: 12780750
[TBL] [Abstract][Full Text] [Related]
6. Association of HLA-DR, -DQ genotype and CTLA-4 gene polymorphism with Graves' disease in Japanese children.
Iwama S; Ikezaki A; Kikuoka N; Kim HS; Matsuoka H; Yanagawa T; Sato H; Hoshi M; Sakamaki T; Sugihara S
Horm Res; 2005; 63(2):55-60. PubMed ID: 15640608
[TBL] [Abstract][Full Text] [Related]
7. Graves' disease in Brazilian children and adults: lack of genetic association with CTLA-4 +49A>G polymorphism.
Namo Cury A; Longui CA; Kochi C; Calliari LE; Scalissi N; Salles JE; Neves Rocha M; Barbosa de Melo M; Rezende Melo M; Monte O
Horm Res; 2008; 70(1):36-41. PubMed ID: 18493148
[TBL] [Abstract][Full Text] [Related]
8. CTLA4 gene polymorphism confers susceptibility to Graves' disease in Japanese.
Yanagawa T; Taniyama M; Enomoto S; Gomi K; Maruyama H; Ban Y; Saruta T
Thyroid; 1997 Dec; 7(6):843-6. PubMed ID: 9459626
[TBL] [Abstract][Full Text] [Related]
9. Soluble CTLA-4 receptor an immunological marker of Graves' disease and severity of ophthalmopathy is associated with CTLA-4 Jo31 and CT60 gene polymorphisms.
Daroszewski J; Pawlak E; Karabon L; Frydecka I; Jonkisz A; Slowik M; Bolanowski M
Eur J Endocrinol; 2009 Nov; 161(5):787-93. PubMed ID: 19734241
[TBL] [Abstract][Full Text] [Related]
10. Influence of the TSH receptor gene on susceptibility to Graves' disease and Graves' ophthalmopathy.
Yin X; Latif R; Bahn R; Tomer Y; Davies TF
Thyroid; 2008 Nov; 18(11):1201-6. PubMed ID: 18925838
[TBL] [Abstract][Full Text] [Related]
11. Associations between autoimmune thyroid disease prognosis and functional polymorphisms of susceptibility genes, CTLA4, PTPN22, CD40, FCRL3, and ZFAT, previously revealed in genome-wide association studies.
Inoue N; Watanabe M; Yamada H; Takemura K; Hayashi F; Yamakawa N; Akahane M; Shimizuishi Y; Hidaka Y; Iwatani Y
J Clin Immunol; 2012 Dec; 32(6):1243-52. PubMed ID: 22706687
[TBL] [Abstract][Full Text] [Related]
12. [Association of polymorphism of protein tyrosine phosphatase nonreceptor-22 gene with AITD].
Yu ZY; Zhang JA; Maier HB; Wang Y; Xiao WX; Quan Y; Dong BN
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Aug; 24(8):804-7. PubMed ID: 18687223
[TBL] [Abstract][Full Text] [Related]
13. A significant association of the CTLA4 gene variants with the risk of autoimmune Graves' disease in ethnic Kashmiri population.
Shehjar F; Dil-Afroze ; Misgar RA; Malik SA; Laway BA
Cell Immunol; 2020 Jan; 347():103995. PubMed ID: 31708111
[TBL] [Abstract][Full Text] [Related]
14. Synergistic combined effect between CD40-1C>T and CTLA-4+6230G>A polymorphisms in Graves' disease.
Chen X; Hu Z; Li W; Wu P; Liu M; Bao L; Wu M; Fang S; Xiong W; Chen M; Wu G
Gene; 2015 Aug; 567(2):154-8. PubMed ID: 25936345
[TBL] [Abstract][Full Text] [Related]
15. CT60 single nucleotide polymorphisms of the cytotoxic T-lymphocyte-associated antigen-4 gene region is associated with Graves' disease in an Italian population.
Petrone A; Giorgi G; Galgani A; Alemanno I; Corsello SM; Signore A; Di Mario U; Nisticò L; Cascino I; Buzzetti R
Thyroid; 2005 Mar; 15(3):232-8. PubMed ID: 15785242
[TBL] [Abstract][Full Text] [Related]
16. Relation of three polymorphisms of the CTLA-4 gene in patients with Graves' disease.
Kouki T; Gardine CA; Yanagawa T; Degroot LJ
J Endocrinol Invest; 2002 Mar; 25(3):208-13. PubMed ID: 11936461
[TBL] [Abstract][Full Text] [Related]
17. HLA and CTLA4 polymorphisms may confer a synergistic risk in the susceptibility to Graves' disease.
Takahashi M; Kimura A
J Hum Genet; 2010 May; 55(5):323-6. PubMed ID: 20300120
[TBL] [Abstract][Full Text] [Related]
18. CTLA-4 gene A-G polymorphism and childhood Graves' disease.
Yung E; Cheng PS; Fok TF; Wong GW
Clin Endocrinol (Oxf); 2002 May; 56(5):649-53. PubMed ID: 12030917
[TBL] [Abstract][Full Text] [Related]
19. Association of CTLA-4 and IL-13 gene polymorphisms with Graves' disease and ophthalmopathy in Chinese children.
Chong KK; Chiang SW; Wong GW; Tam PO; Ng TK; Hu YJ; Yam GH; Lam DS; Pang CP
Invest Ophthalmol Vis Sci; 2008 Jun; 49(6):2409-15. PubMed ID: 18296657
[TBL] [Abstract][Full Text] [Related]
20. Lymphoid tyrosine phosphatase (PTPN22/LYP) variant and Graves' disease in a Polish population: association and gene dose-dependent correlation with age of onset.
Skórka A; Bednarczuk T; Bar-Andziak E; Nauman J; Ploski R
Clin Endocrinol (Oxf); 2005 Jun; 62(6):679-82. PubMed ID: 15943829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
